Table 6.
The correlation between LINC00261 expression and clinical features in 229 patients with PCa
| All cases | LINC00261 | |||
|---|---|---|---|---|
|
| ||||
| High expression | Low expression | P value | ||
| Age (year) | 0.446 | |||
| > 60 | 108 | 57 (52.8%) | 51 (47.2%) | |
| ≤ 60 | 121 | 66 (54.5%) | 55 (45.5%) | |
| Differentiation | 0.348 | |||
| Well | 69 | 34 (49.3%) | 35 (50.7%) | |
| Moderate | 87 | 46 (52.9%) | 41 (47.1%) | |
| Poor | 73 | 39 (53.4%) | 34 (46.6%) | |
| pN status | 0.018 | |||
| N0 | 123 | 75 (61.0%) | 48 (39.0%) | |
| N1-N2 | 106 | 49 (46.2%) | 57 (53.8%) | |
| pM status | 0.214 | |||
| M0 | 156 | 83 (53.2%) | 73 (46.8%) | |
| M1 | 73 | 34 (46.6%) | 39 (53.4%) | |
| Clinical stage | 0.092 | |||
| I | 79 | 47 (59.5%) | 32 (40.5%) | |
| II | 58 | 35 (60.3%) | 23 (39.7%) | |
| III | 53 | 21 (39.6%) | 32 (60.4%) | |
| IV | 39 | 18 (46.2%) | 21 (53.8%) | |
pN: pathological node; pM: pathological metastasis.